"Blood Component Removal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any procedure in which blood is withdrawn from a donor, a portion is separated and retained and the remainder is returned to the donor.
| Descriptor ID |
D001781
|
| MeSH Number(s) |
E02.120
|
| Concept/Terms |
Blood Component Removal- Blood Component Removal
- Blood Component Removals
- Component Removal, Blood
- Component Removals, Blood
- Removal, Blood Component
- Removals, Blood Component
- Pheresis
- Phereses
- Apheresis
- Aphereses
|
Below are MeSH descriptors whose meaning is more general than "Blood Component Removal".
Below are MeSH descriptors whose meaning is more specific than "Blood Component Removal".
This graph shows the total number of publications written about "Blood Component Removal" by people in this website by year, and whether "Blood Component Removal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 8 | 4 | 12 |
| 2018 | 4 | 4 | 8 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 1 | 2 |
| 2021 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Blood Component Removal" by people in Profiles.
-
Challenges in Establishing a Coronavirus Disease 2019 (COVID-19) Convalescent Plasma Donation Program in a Multicultural Environment. Arch Pathol Lab Med. 2021 12 01; 145(12):1479-1484.
-
Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light. Transfus Clin Biol. 2022 Feb; 29(1):31-36.
-
Successful Treatment of a 39-Year-Old COVID-19 Patient with Respiratory Failure by Selective C-Reactive Protein Apheresis. Am J Case Rep. 2021 Aug 05; 22:e932964.
-
Case Report: C-Reactive Protein Apheresis in a Patient With COVID-19 and Fulminant CRP Increase. Front Immunol. 2021; 12:708101.
-
Apheresis physician well-being during the COVID-19 pandemic: Results of a survey. Transfusion. 2021 05; 61(5):1542-1550.
-
COVID-19 convalescent plasma donor characteristics, product disposition, and comparison with standard apheresis donors. Transfusion. 2021 05; 61(5):1471-1478.
-
Why continued lipoprotein apheresis is vital for homozygous familial hypercholesterolemia patients with COVID-19. J Clin Lipidol. 2021 Mar-Apr; 15(2):379-380.
-
Collateral damage of the COVID-19 pandemic on the management of homozygous familial hypercholesterolemia. J Clin Lipidol. 2021 Mar-Apr; 15(2):381-382.
-
Social distancing in apheresis medicine. Transfusion. 2020 11; 60(11):2758-2759.
-
Impact of COVID-19 in the attendance of blood donors and production on a Brazilian Blood Centres. Transfus Med. 2021 Jun; 31(3):206-212.